Singapore, Oct. 16 -- A new collaboration between Texas Medical Center, the world's largest innovation hub, and the Osong Medical Innovation Foundation (KBIOHealth), South Korea's leading national medical initiative, is set to accelerate the market entry and commercialisation of Korean startups in the United States through the TMC | Republic of Korea BioBridge.

Under a new Memorandum of Understanding, both organisations will create gateway opportunities for entrepreneurs, researchers, clinicians, and industry partners. The partnership will also foster clinical research and facilitate collaborative projects and policy dialogues to advance innovation and commercialization across public, private and academic sectors.

"Expanding biomanufact...